Peyronie's: Researchers give nod to autologous grafts
Las Vegas- In their first experiences with xenografts for Peyronie's disease, surgeons at the Mayo Clinic in Jacksonville, FL, decided that Surgisis (Cook Biotech Incorporated, West Lafayette, IN) worked better than Tutoplast (IOP, Inc., Costa Mesa, CA), but the surgeons said they still prefer autologous grafts.
Jonathan E. Rosenberg, MD, discusses the FDA approval of perioperative durvalumab plus enfortumab vedotin and considerations for treatment selection in cisplatin-ineligible MIBC.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.